HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nipon Chattipakorn Selected Research

T-Type Calcium Channels (T-Type Calcium Channel)

1/2022Iron overload cardiomyopathy: Using the latest evidence to inform future applications.
12/2019Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.
3/2018Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
1/2018Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
3/2017Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
1/2017Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nipon Chattipakorn Research Topics

Disease

98Mitochondrial Diseases (Mitochondrial Disease)
02/2024 - 05/2011
79Inflammation (Inflammations)
01/2024 - 05/2011
73Insulin Resistance
12/2023 - 03/2011
48Reperfusion Injury
10/2023 - 07/2008
45Cognitive Dysfunction
05/2024 - 10/2014
45Obesity
12/2023 - 07/2009
44Iron Overload
03/2024 - 04/2009
38Ischemia
01/2023 - 07/2008
34Infarction (Infarctions)
10/2023 - 08/2011
26Neoplasms (Cancer)
01/2024 - 02/2015
25Cardiotoxicity
04/2024 - 01/2020
24Cardiomyopathies (Cardiomyopathy)
12/2023 - 04/2009
24Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 01/2005
24Left Ventricular Dysfunction
10/2023 - 10/2011
24Cardiac Arrhythmias (Arrythmia)
01/2023 - 03/2006
23Heart Failure
01/2024 - 09/2006
19Myocardial Infarction
01/2024 - 07/2007
18Body Weight (Weight, Body)
01/2022 - 07/2009
17Thalassemia
02/2023 - 02/2011
15Myocardial Ischemia (Ischemic Heart Diseases)
10/2023 - 07/2008
15Type 2 Diabetes Mellitus (MODY)
01/2022 - 08/2011
15Ventricular Fibrillation
01/2020 - 05/2003
13Alzheimer Disease (Alzheimer's Disease)
05/2024 - 03/2007
13Neuroinflammatory Diseases
05/2024 - 01/2021
12Dysbiosis
05/2024 - 01/2017
12Fibrosis (Cirrhosis)
03/2024 - 06/2015
12Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2022 - 01/2015
11Acute Lung Injury
02/2024 - 11/2021
9Heart Diseases (Heart Disease)
11/2023 - 05/2011
8Anemia
03/2024 - 01/2016
8Prediabetic State (Prediabetes)
10/2023 - 10/2018
6Breast Neoplasms (Breast Cancer)
04/2024 - 01/2020
6Chemotherapy-Related Cognitive Impairment
04/2024 - 01/2020
6Osteoporosis
11/2023 - 02/2016
6Encephalitis (Encephalitis, Rasmussen)
01/2023 - 01/2016
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 04/2008
5Infections
11/2023 - 04/2008
5Sepsis (Septicemia)
11/2023 - 12/2016
5Brain Ischemia (Cerebral Ischemia)
04/2023 - 11/2020
5Pain (Aches)
02/2022 - 04/2018
5Hyperglycemia
01/2021 - 08/2017
4Cardiomegaly (Heart Hypertrophy)
01/2024 - 01/2016

Drug/Important Bio-Agent (IBA)

59Insulin (Novolin)FDA Link
12/2023 - 03/2011
41IronIBA
11/2023 - 04/2009
34Proteins (Proteins, Gene)FDA Link
03/2024 - 09/2006
30Metformin (Glucophage)FDA LinkGeneric
02/2023 - 08/2012
27Doxorubicin (Adriamycin)FDA LinkGeneric
05/2024 - 01/2020
22Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 05/2011
22VildagliptinIBA
01/2019 - 08/2012
20Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2016
19Glucose (Dextrose)FDA LinkGeneric
10/2022 - 07/2009
18CytokinesIBA
11/2023 - 07/2012
16salicylhydroxamic acid (SHAM)IBA
01/2023 - 12/2014
16Estrogens (Estrogen)FDA Link
12/2022 - 11/2011
16Testosterone (Sustanon)FDA Link
12/2020 - 01/2015
15AntioxidantsIBA
03/2024 - 04/2008
14LipidsIBA
10/2022 - 11/2015
13CalciumIBA
01/2024 - 02/2011
13Dipeptidyl-Peptidase IV InhibitorsIBA
12/2018 - 07/2013
12fibroblast growth factor 21IBA
02/2023 - 11/2015
11Chelating AgentsIBA
10/2022 - 01/2014
10MelatoninIBA
08/2023 - 11/2018
10Transferrin (beta 2 Transferrin)IBA
01/2022 - 06/2012
9Donepezil (Aricept)FDA LinkGeneric
05/2024 - 01/2021
9Galactose (Galactopyranose)FDA LinkGeneric
12/2023 - 01/2018
8Indicators and Reagents (Reagents)IBA
11/2023 - 07/2007
8Trastuzumab (Herceptin)FDA Link
11/2023 - 01/2020
8DeferiproneIBA
02/2023 - 01/2014
8CholesterolIBA
06/2021 - 08/2012
8Insulin ReceptorIBA
01/2019 - 11/2011
7Amyloid beta-PeptidesIBA
05/2024 - 07/2017
73- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA
10/2023 - 01/2018
7Neuroprotective AgentsIBA
01/2023 - 01/2018
7Caspase 3 (Caspase-3)IBA
11/2022 - 05/2013
7dapagliflozinIBA
10/2021 - 10/2017
7PrebioticsIBA
12/2020 - 01/2017
7Atorvastatin (Lipitor)FDA Link
10/2020 - 01/2016
6Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2024 - 03/2007
6Cysteine (L-Cysteine)FDA Link
01/2023 - 01/2014
6T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2022 - 01/2017
6humaninIBA
01/2022 - 01/2016
6Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 10/2017
6Malondialdehyde (Propanedial)IBA
10/2020 - 06/2012
5CreatinineIBA
04/2024 - 01/2016
5hemoglobin Bart'sIBA
03/2024 - 04/2018
5Oxygen (Dioxygen)IBA
02/2024 - 10/2011
5Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2023 - 11/2021
5SodiumIBA
01/2022 - 10/2017
5Connexin 43 (Connexin43)IBA
01/2018 - 02/2013
4LipopolysaccharidesIBA
01/2024 - 01/2018
4necrostatin-1IBA
11/2023 - 01/2020
4human ERBB2 proteinIBA
11/2023 - 04/2020
4Cholinergic ReceptorsIBA
09/2023 - 08/2018

Therapy/Procedure

52Therapeutics
01/2024 - 01/2005
17Drug Therapy (Chemotherapy)
04/2024 - 03/2007
12Vagus Nerve Stimulation
11/2023 - 11/2013
6Blood Transfusion (Blood Transfusions)
01/2022 - 02/2011
6Glycemic Control
10/2021 - 07/2013
5Caloric Restriction
12/2023 - 01/2019
4Hyperbaric Oxygenation
11/2023 - 01/2021